Check back frequently to get the latest news about Onduo. For inquiries, please contact us at email@example.com.
Onduo released a whitepaper on the use of continuous glucose monitoring systems (CGMs) for type 2 diabetes care as part of a whole person health approach that supports people between visits with their primary care providers (PCPs).
Onduo Data Presented at American Diabetes Association’s (ADA) 80th Scientific Sessions Highlights Meaningfully Lowered Hemoglobin A1C in People with T2D, with Significantly Greater Reductions in Participants Using Continuous Glucose Monitoring.
Onduo announced Dr. Vindell Washington will step in as interim CEO to lead the company during its next stage of growth. Vindell joined Verily as chief clinical officer of Health Platforms in January. Dr. Josh Riff, who has served as CEO since the launch of Onduo in 2016 is leaving to pursue other early-stage entrepreneurial opportunities.
Onduo shared positive research findings from the use of continuous glucose monitoring (CGM) systems by adults with type 2 diabetes participating in its virtual diabetes clinic. In a presentation at the 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), Onduo revealed results of a satisfaction survey completed by 594 members who wore a CGM.